Cancer & Cardiovascular Disease: Impacts at All Ages

While cancer survivorship rates continue to improve, there are CVD-related complications for patients before, during, and after cancer treatment. Guests Chelsea Kriesberg, DNP, CPNP-AC, CCRN, and Lisa Nodzon, PhD, APRN, AOCNP, describe the intersection of cancer and cardiovascular disease across the lifespan. Collaborative, team-based, and life-long care is illustrated in through a case-based discussion.

Cardiovascular risk calculator: https://ccss.stjude.org/resources/calculators/cardiovascular-risk-calculator.html

Cardiac Disease in Childhood Cancer Survivors: Risk Prediction, Prevention, and Surveillance. Leerink, J, de Baat, E, Feijen, E. et al. Cardiac Disease in Childhood Cancer Survivors: Risk Prediction, Prevention, and Surveillance: JACC CardioOncology State-of-the-Art Review. J Am Coll Cardiol CardioOnc. 2020 Sep, 2 (3) 363–378.https://doi.org/10.1016/j.jaccao.2020.08.006

Cardioprotective impacts of dexrazoxane: Lipshultz SE, Scully RE, Lipsitz SR, et al. Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial. Lancet Oncol. 2010 Oct;11(10):950-61. doi: 10.1016/S1470-2045(10)70204-7. Epub 2010 Sep 16. PMID: 20850381; PMCID: PMC3756093.

Improving quality and quantity of life for childhood cancer survivors: Ehrhardt MJ, Krull KR, Bhakta N, et al. Improving quality and quantity of life for childhood cancer survivors globally in the twenty-first century. Nat Rev Clin Oncol. 2023 Oct;20(10):678-696. doi: 10.1038/s41571-023-00802-w. Epub 2023 Jul 24. PMID: 37488230.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.